REPOTRECTINIB for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 14 adverse event reports in the FDA FAERS database where REPOTRECTINIB was used for Lung neoplasm malignant.

Most Reported Side Effects for REPOTRECTINIB

Side Effect	Reports	%	Deaths	Hosp.
Dizziness	32	17.1%	1	7
Death	21	11.2%	20	1
Nausea	12	6.4%	0	2
Adverse event	11	5.9%	1	6
Neuropathy peripheral	11	5.9%	0	2
Off label use	10	5.4%	1	2
Paraesthesia	10	5.4%	0	0
Balance disorder	9	4.8%	0	1
Pain	9	4.8%	0	1
Hospitalisation	8	4.3%	0	8
Muscular weakness	8	4.3%	0	1
Anaemia	7	3.7%	0	5
Fatigue	7	3.7%	0	0
Gait disturbance	7	3.7%	0	3
Taste disorder	7	3.7%	0	0